🔎 Trials Near Me

Hjem › Interstitielle lungesygdomme › Pennsylvania

Interstitielle lungesygdomme kliniske forsøg i Pennsylvania

18 studier for Interstitielle lungesygdomme søger deltagere på steder i Pennsylvania.

Byer i Pennsylvania

Officiel studietekst (engelsk)

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

  • University of Pennsylvania, Philadelphia
  • Temple University, Philadelphia
  • University of Pittsburgh Medical Center, Pittsburgh
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07540988

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

  • University of Pennsylvania, Philadelphia
RekruttererFase 3
Alder 40 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07201922

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • Thomas Jefferson University, Philadelphia
  • Temple Lung Center, Temple University, Philadelphia
  • UPMC Montefiore, Pittsburgh
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 29. sep. 2026 · NCT05798923

A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)

  • GSK Investigational Site, Philadelphia
  • GSK Investigational Site, Philadelphia
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06716606

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

  • GSK Investigational Site, Philadelphia
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06572384

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  • GSK Investigational Site, Philadelphia
  • GSK Investigational Site, Philadelphia
  • GSK Investigational Site, Pittsburgh
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT05878717

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • Thomas Jefferson University, Philadelphia
  • Temple University of The Commonwealth System of Higher Education, Philadelphia
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT06911632

Dorothy P. and Richard P. Simmons Center for ILD Research Registry

  • Michelle F MacPherson, Pittsburgh
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 27. aug. 2026 · NCT00258583

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • St. Luke's University Health Network, Bethlehem
  • University of Pennsylvania, Philadelphia
  • Thomas Jefferson University - Sidney Kimmel Medical College, Philadelphia
  • og 2 flere
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 26. aug. 2026 · NCT06388421

Platform Clinical Study for Conquering Scleroderma

  • University of Pennsylvania, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT06195072

Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis

  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
  • University of Pittsburgh Medical Center, Pittsburgh
  • University of Pittsburgh Medical Center, Pittsburgh
RekruttererFase 2
Alder 8 til 60 · Alle køn · Opdateret 14. aug. 2026 · NCT03630211

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • Temple University, Philadelphia
  • Thomas Jefferson University, Philadelphia
RekruttererObservationsstudie
Alder 21 og opefter · Alle køn · Opdateret 12. aug. 2026 · NCT01915511

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

  • Temple University, Philadelphia
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 10. aug. 2026 · NCT07175038

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  • Pennsylvania State Hershey Medical Center and College of Medicine, Hershey
  • Hospital of the University of Pennsylvania, Philadelphia
  • Jefferson Honickman Center, Philadelphia
  • og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT05943535

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

  • Children's Hospital of Philadelphia, Philadelphia
RekruttererObservationsstudie
Op til 24 år · Alle køn · Opdateret 22. jun. 2026 · NCT04098445

Feasibility of Semaglutide in Advanced Lung Disease

  • University of Pennsylvania Perelman School of Medicine, Philadelphia
RekruttererFase 1/2
Alder 18 til 80 · Alle køn · Opdateret 21. apr. 2026 · NCT05746039

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

  • Temple University Hospital-Temple Lung Center, Philadelphia
RekruttererFase 2
Alder 40 og opefter · Alle køn · Opdateret 12. nov. 2025 · NCT05975983

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.